{"id":3154,"date":"2026-03-17T11:48:40","date_gmt":"2026-03-17T11:48:40","guid":{"rendered":"https:\/\/schloss-apotheke-kuemmersbruck.de\/produkte\/?p=3154"},"modified":"2026-03-17T11:48:40","modified_gmt":"2026-03-17T11:48:40","slug":"vima-startet-phase-ii-studien-fuer-parkinson-und-dystonie","status":"publish","type":"post","link":"https:\/\/schloss-apotheke-kuemmersbruck.de\/produkte\/vima-startet-phase-ii-studien-fuer-parkinson-und-dystonie\/","title":{"rendered":"Vima startet Phase-II-Studien f\u00fcr Parkinson und Dystonie"},"content":{"rendered":"<p>Das Biotech-Unternehmen Vima Therapeutics aus Massachusetts hat zus\u00e4tzliche 40 Millionen US-Dollar f\u00fcr seine Serie-A-Finanzierung erhalten. Damit soll die Entwicklung des Medikaments VIM0423 f\u00fcr Parkinson und Dystonie vorangetrieben werden. Insgesamt hat Vima nun 100 Millionen US-Dollar an Investitionen erhalten, darunter von neuen und bestehenden Investoren wie Frazier Life Sciences, Atlas Venture, Access Industries und Canaan Partners. Vima wurde im Mai 2025 mit dem Ziel gegr\u00fcndet, das erste orale Medikament gegen Dystonie zu entwickeln. Mit dem neuen Kapital wird Vima nun zwei Phase-II-Studien durchf\u00fchren: eine f\u00fcr Dystonie und eine f\u00fcr Parkinson. VIM0423 ist ein selektiver Muskarin-Cholinrezeptor-Antagonist, der gezielt Rezeptoren im Gehirn anspricht, um Nebenwirkungen wie Durchfall zu vermeiden. Die Studie f\u00fcr Dystonie hat bereits begonnen, die f\u00fcr Parkinson soll Mitte 2026 starten. Erste Ergebnisse werden f\u00fcr die erste H\u00e4lfte des Jahres 2027 erwartet. Derzeit gibt es verschiedene Behandlungsm\u00f6glichkeiten f\u00fcr Dystonie, darunter Botox und Kombinationstherapien. Vima hofft, mit VIM0423 eine neue, wirksamere Behandlungsoption anzubieten. &#8216;Dystonie und Parkinson haben \u00e4hnliche Ursachen im Gehirn, und unsere Ergebnisse zeigen, dass wir auf dem richtigen Weg sind&#8217;, sagte Bernard Ravina, Gr\u00fcnder und CEO von Vima.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Das Biotech-Unternehmen Vima Therapeutics aus Massachusetts hat zus\u00e4tzliche 40 Millionen US-Dollar f\u00fcr seine Serie-A-Finanzierung erhalten. Damit soll die Entwicklung des Medikaments VIM0423 f\u00fcr Parkinson und Dystonie vorangetrieben werden. Insgesamt hat Vima nun 100 Millionen US-Dollar an Investitionen erhalten, darunter von neuen und bestehenden Investoren wie Frazier Life Sciences, Atlas Venture, Access Industries und Canaan Partners. [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":3155,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[489],"tags":[],"class_list":["post-3154","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmazeutische-nachrichten"],"_links":{"self":[{"href":"https:\/\/schloss-apotheke-kuemmersbruck.de\/produkte\/wp-json\/wp\/v2\/posts\/3154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/schloss-apotheke-kuemmersbruck.de\/produkte\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/schloss-apotheke-kuemmersbruck.de\/produkte\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/schloss-apotheke-kuemmersbruck.de\/produkte\/wp-json\/wp\/v2\/comments?post=3154"}],"version-history":[{"count":1,"href":"https:\/\/schloss-apotheke-kuemmersbruck.de\/produkte\/wp-json\/wp\/v2\/posts\/3154\/revisions"}],"predecessor-version":[{"id":3163,"href":"https:\/\/schloss-apotheke-kuemmersbruck.de\/produkte\/wp-json\/wp\/v2\/posts\/3154\/revisions\/3163"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/schloss-apotheke-kuemmersbruck.de\/produkte\/wp-json\/wp\/v2\/media\/3155"}],"wp:attachment":[{"href":"https:\/\/schloss-apotheke-kuemmersbruck.de\/produkte\/wp-json\/wp\/v2\/media?parent=3154"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/schloss-apotheke-kuemmersbruck.de\/produkte\/wp-json\/wp\/v2\/categories?post=3154"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/schloss-apotheke-kuemmersbruck.de\/produkte\/wp-json\/wp\/v2\/tags?post=3154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}